Hatice Barut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hatice Barut has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Cemile Haki
Bursa City Hospital, Neurology Department, Bursa/ Türkiye
1 shared publication - Elif Güneş
Department of Endocrinology, Metabolism and Diabetes, Health Sciences University, Bursa State Hospital, Bursa, Turkey
1 shared publication - Hatice Demirci Küçükelyas
Hatice Demirci Küçükelyas, MD, Health Sciences University, Bursa State Hospital, Department of Internal Medicine, Bursa, Turkey
1 shared publication - Muhammet İlKer Kaya
Health Sciences University, Bursa State Hospital, Department of Internal Medicine, Bursa, Turkey
1 shared publication - Mustafa Barut
Bursa City Hospital
1 shared publication - Mutlu Güneş
Health Sciences University, Bursa Yüksek İhtisas Training and Research Hospital, Department of Endocrinology, Metabolism and Diabetes, Bursa, Turkey
1 shared publication
Latest Publications
- 21 January 2026
- Published by Academician Publishing
- p. 327-336
Immunglobulin-G4 İle İlgili Nörolojik Hastalıkların Tedavisi
Immünglobulin-G4 ilişkili hastalık (IgG4-İH), tümör benzeri kitle, lenfoplazmositik hücre infiltrasyonu, storiform fibrozis ve genellikle IgG4 seviyelerinin serumda artmış olduğu multisistemik bir hastalıktır. Çoğunlukla relapsing–remitting formda seyreder ve eş zamanlı ya da ardışık şekilde, birçok organda tutulum yapabilir. 2003 yılında ortak histopatolojik özellikler gösterdiği fark edilen; otoimmun pankreatit tip 1, mikulicz sendromu(sialadenit, dakroadenit), orbital psödotümör, riedel tiroidit, retroperitoneal fibrozis(ormond hastalığı) , küttner sendromu, multifokal fibrosklerozis , mediastinal fibrozis, periaortitis ve periarteritis, idiyopatik hipokomplementemik tubulointerstisyel nefrit, inflamatuvar aortik anevrizma, inflamatuvar psödotümör gibi hastalıklar IgG4-İH çatısı altında toplanmıştır (1). Tanıda ve dolayısıyla tedavide gecikmeler görülmesinin nedeni benign tümoral lezyonlar sanılan bir hastalık olarak algılanmasıdır (2). IgG4-İH, kalıcı organ hasarının engellenmesi için erken tanı konulması gereken multisistemik bir hastalık olup en sık görülen nörolojik belirtiler hipertrofik pakimeningit ve hipofizittir.
- 21 January 2026
- Published by Academician Publishing
- p. 327-336
Immunglobulin-G4 İle İlgili Nörolojik Hastalıkların Tedavisi
Immünglobulin-G4 ilişkili hastalık (IgG4-İH), tümör benzeri kitle, lenfoplazmositik hücre infiltrasyonu, storiform fibrozis ve genellikle IgG4 seviyelerinin serumda artmış olduğu multisistemik bir hastalıktır. Çoğunlukla relapsing–remitting formda seyreder ve eş zamanlı ya da ardışık şekilde, birçok organda tutulum yapabilir. 2003 yılında ortak histopatolojik özellikler gösterdiği fark edilen; otoimmun pankreatit tip 1, mikulicz sendromu(sialadenit, dakroadenit), orbital psödotümör, riedel tiroidit, retroperitoneal fibrozis(ormond hastalığı) , küttner sendromu, multifokal fibrosklerozis , mediastinal fibrozis, periaortitis ve periarteritis, idiyopatik hipokomplementemik tubulointerstisyel nefrit, inflamatuvar aortik anevrizma, inflamatuvar psödotümör gibi hastalıklar IgG4-İH çatısı altında toplanmıştır (1). Tanıda ve dolayısıyla tedavide gecikmeler görülmesinin nedeni benign tümoral lezyonlar sanılan bir hastalık olarak algılanmasıdır (2). IgG4-İH, kalıcı organ hasarının engellenmesi için erken tanı konulması gereken multisistemik bir hastalık olup en sık görülen nörolojik belirtiler hipertrofik pakimeningit ve hipofizittir.
- Open Access
- 29 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 81-89
Clinical comparison of acute stroke cases with and without COVID-19
Background We aimed to assess acute stroke cases with and without coronavirus disease 2019 (COVID-19) positivity concerning clinical features and the number of hospitalizations acute stroke cases compared to the previous year. Methods Acute stroke patients with and without COVID-19 positivity, including those who were hospitalized in the neurology service and intensive care unit of tertiary healthcare center between 17 December 2020 and 31 January 2021 due to acute stroke, were included in this cross-sectional study. Results Mortality (p=0.042) and mechanical ventilation use (p=0.041) were more frequent in COVID-19-positive stroke patients compared to those without COVID-19. The most common type of stroke in COVID-19-positive acute stroke patients was ischemic stroke (69.23%). Additionally, stroke patients with COVID-19 had a significantly higher percentage of kidney disease compared to those without COVID-19 (p=0.009). We also observed that the number of acute stroke cases hospitalized in our hospital during the pandemic decreased significantly compared to the previous year (p=0.036). Conclusion Since the majority of our patients were diagnosed with COVID-19 after admission to the hospital due to stroke, it should be kept in mind that patients who apply to the hospital with stroke symptoms may also have COVID-19, even if they are asymptomatic.
- 29 April 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (2) , 81-89
Open AccessClinical comparison of acute stroke cases with and without COVID-19
Background We aimed to assess acute stroke cases with and without coronavirus disease 2019 (COVID-19) positivity concerning clinical features and the number of hospitalizations acute stroke cases compared to the previous year. Methods Acute stroke patients with and without COVID-19 positivity, including those who were hospitalized in the neurology service and intensive care unit of tertiary healthcare center between 17 December 2020 and 31 January 2021 due to acute stroke, were included in this cross-sectional study. Results Mortality (p=0.042) and mechanical ventilation use (p=0.041) were more frequent in COVID-19-positive stroke patients compared to those without COVID-19. The most common type of stroke in COVID-19-positive acute stroke patients was ischemic stroke (69.23%). Additionally, stroke patients with COVID-19 had a significantly higher percentage of kidney disease compared to those without COVID-19 (p=0.009). We also observed that the number of acute stroke cases hospitalized in our hospital during the pandemic decreased significantly compared to the previous year (p=0.036). Conclusion Since the majority of our patients were diagnosed with COVID-19 after admission to the hospital due to stroke, it should be kept in mind that patients who apply to the hospital with stroke symptoms may also have COVID-19, even if they are asymptomatic.